Sign up to save your podcasts
Or
Share Intranasal CGRP for migraine, ultrasound ablation for Parkinson's disease, novel therapeutic pathway for Duchenne muscular atrophy.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Intranasal CGRP for migraine, ultrasound ablation for Parkinson's disease, novel therapeutic pathway for Duchenne muscular atrophy.
In this week's podcast, Neurology Today's editor-in-chief discusses the newly approved zavegepant for migraine, the potential/caveats of ultrasound ablation for Parkinson's disease, the transational potential of a new therapeutic target for Duchenne muscular atrophy.
View all episodes
By American Academy of Neurology
4.7
1919 ratings
In this week's podcast, Neurology Today's editor-in-chief discusses the newly approved zavegepant for migraine, the potential/caveats of ultrasound ablation for Parkinson's disease, the transational potential of a new therapeutic target for Duchenne muscular atrophy.
More shows like Neurology Today in 5
View all
JAMA Editors' Summary
136 Listeners
NEJM This Week
318 Listeners
JAMA Clinical Reviews
498 Listeners
Neurology® Podcast
299 Listeners
Practical Neurology Podcast
51 Listeners
JAMA Neurology Author Interviews
12 Listeners
Annals On Call Podcast
193 Listeners
JAMA Medical News
94 Listeners
The Clinical Problem Solvers
512 Listeners
Neurology Minute
134 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Neurology Exam Prep Podcast
190 Listeners
The Curious Clinicians
370 Listeners
The Lancet Neurology in conversation with
6 Listeners
Continuum Audio
81 Listeners